Commodore Capital »

Research Alliance Corp Iii shares owned by Commodore Capital

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by Commodore Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.4M 500k 10.70

More positions owned by Commodore Capital

Relay Therapeutics (RLAY)
Enliven Therapeutics (ELVN)
Alkermes SHS (ALKS)
Cogent Biosciences (COGT)
Amylyx Pharmaceuticals (AMLX)
Definium Therapeutics Com Shs (DFTX)
Spyre Therapeutics Com New (SYRE)
Alto Neuroscience Com Shs (ANRO)
Tango Therapeutics (TNGX)
Eyepoint Com New (EYPT)
Tyra Biosciences (TYRA)
Damora Therapeutics Com New (DMRA)
Celldex Therapeutics Com New (CLDX)
Pharvaris N V (PHVS)
Lb Pharmaceuticals Com Shs (LBRX)

View all positions for Commodore Capital

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii